by Clinical Neuropsychologist Online | Friday, July 31, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 8, August 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 31, 2026 Neuro-Dementia Previous...
by Clinical Neuropsychologist Online | Friday, July 31, 2026 | Dementia
Abstract INTRODUCTION Vascular risk factors (VRFs) contribute to white matter microstructural degeneration, but their tract-specific contributions are unclear. We assessed the independent associations of four major VRFs with white matter microstructure in a large,...
by Clinical Neuropsychologist Online | Friday, July 31, 2026 | Dementia
Abstract INTRODUCTION While most studies of Alzheimer’s disease (AD) examine cross-sectional relationships among biomarkers, longitudinal relationships are also highly relevant. METHODS This study in the Alzheimer’s Disease Neuroimaging Initiative cohort...
by Clinical Neuropsychologist Online | Friday, July 31, 2026 | Dementia
Abstract INTRODUCTION Plasma phosphorylated tau 217 (p-tau217) is a promising biomarker for monitoring treatment response in Alzheimer’s disease (AD), but its longitudinal dynamics and clinical relevance remain unclear. METHODS In this prospective real-world...
by Clinical Neuropsychologist Online | Friday, July 31, 2026 | Dementia
Abstract Mild cognitive impairment (MCI), a prodromal stage of Alzheimer’s disease (AD), remains undiagnosed in > 90% of individuals, delaying access to timely evaluation and interventions. Self-administered digital cognitive assessments (SA-DCAs) offer...
